This week, we’re delighted to be joined by Annemie Ribbens, VP Science, Evidence and Trials at icometrix, a medical technology manufacturer that offers a portfolio of AI solutions to assist healthcare with various challenges in neurological disorders, such as brain trauma, strokes, dementia, and Alzheimer's disease.

During this episode, Annemie opens up on icometrix’s mission in analyzing and treating neurological disorders, the work that went into developing the data infrastructure and the challenges they face when dealing with such large data sets. Annemie also goes on to discuss how machine learning will influence the application of precision medicine in biotech over the next five years and the goals that the company is looking to achieve in the future.

Data in Biotech is a fortnightly podcast exploring how companies leverage data innovation in life sciences.

Chapter Markers:

[1:14] Annemie provides us with a brief introduction into her background and what led her to pursue a career in this field.

[4:17] Ross asks Annemie about icometrix’s portfolio and what differentiates it from the other tools in the market.

[7:36] Annemie explains how icometrix are helping physicians improve both their understanding and treatment of particular disorders.

[13:31] Annemie dives into the role that the public patient facing app plays and how the data that it gathers feeds the ecosystem.

[22:03] Annemie reveals how their partnerships work.

[28:11] Ross asks Annemie to provide some insights into how icometrix went about developing their data infrastructure.

[31:23] Annemie shares the channels involved when processing and analysing large data sets.

[40:01] Annemie explains the methodology that enables icometrix to know what core areas to focus on.

[43:07] Annemie reveals one of the projects that she is most proud of.

[45:00] Annemie gives us her thoughts on what the future holds for machine learning.

[47:33] Annemie explains where listeners can go to find out more information on icometrix.

---

If you’re a biotech company struggling to unlock a data challenge, CorrDyn can help.

Whether you need to supplement existing technology teams with specialist expertise or launch a data program that lays the groundwork for future internal hires, you can partner with Corrdyn to unlock the potential of your business data - today.

Visit connect.corrdyn.com/biotech to learn more.

[EXTRAIT] L’IA et l’avenir de l’information | Louis Dreyfus

🎙️ Sponsors du mois